BMS reports mixed results for Opdivo in lung cancer trial - Drug Development Technology

BMS reports mixed results for Opdivo in lung cancer trial  Drug Development Technology

BMS has reported mixed results from the Phase III CheckMate -227 trial of Opdivo in combination with chemotherapy or its other drug Yervoy.